Independent information services
Guides, comparisons, and research summaries for people building a safer, more structured plan around ibogaine and sobriety.
Independent guidance for safer, structured ibogaine aftercare decisions.
What this resource provides
Suturefield does not provide treatment or medical care. It organizes questions, known risks, and follow-through steps so people and supporters can discuss them with appropriate licensed professionals.
Structured checklists bring attention to cardiac safety, medication continuity, overdose prevention, mental-health follow-up, and relapse planning. The aftercare checklist turns broad concerns into topics that can be reviewed before and after ibogaine use.
Medication decisions can carry serious consequences. Our medication guidance helps readers identify questions to bring to a pharmacist or prescribing clinician rather than treating a general guide as individualized advice.
Recovery planning is more durable when it includes what happens next: support, housing, routines, appointments, and an emergency response. The broader ibogaine aftercare resource maps these considerations in plain language for people and families.
We distinguish early or limited evidence from established treatment pathways and point readers toward questions that remain unresolved. For background on the substance itself, ibogaine’s reference overview offers a starting point, not a safety clearance.
How to use the material
These materials are designed to make risk and continuity visible, especially when a person is moving from an intense experience back into ordinary life.
Evidence before claims
Ibogaine is associated with significant safety concerns, including cardiac risk and dangerous interactions. The National Institute on Drug Abuse’s ibogaine overview notes that its safety and effectiveness remain active research questions.
For people considering alcohol-related recovery planning, a separate ibogaine treatment for alcoholism resource may help frame the questions being asked, while Suturefield’s approach and principles explain why independent information should never be mistaken for clinical direction.
“The useful question is not whether information can replace care. It cannot. The question is whether clearer information can make the next care decision safer.” Suturefield approach
Frequently asked questions
No. Suturefield is an independent information resource. It does not diagnose, prescribe, monitor, or arrange treatment, and its guides are not a substitute for advice from a qualified clinician.
Aftercare is where safety planning meets daily life. Substance use disorder is recognized as a treatable health condition, and the SAMHSA National Helpline guidance identifies treatment referral and recovery support as routes to ongoing help.
They are for people considering or recovering from ibogaine use, and for families and supporters trying to understand what safer follow-through can involve. They are intended to support—not replace—professional assessment and emergency care when needed.
Start with the essentials
Explore the checklist to organize the next steps around safety, support, medication continuity, and a response plan for setbacks.
Review the aftercare checklist